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Introduction {#sec1}
============

In living organisms, hundreds of DNA-binding proteins carry out a plethora of roles in homeostasis, in transcriptional regulation in response to stress, and in the maintenance and transmission of genetic information. These DNA-binding proteins do so faithfully due to their distinct DNA-binding specificity toward their cognate DNA sites. Yet, it remains unclear how related proteins, sometimes with a very similar DNA-recognition motif, can recognize entirely different DNA sites. What were the changes at the molecular level that brought about the diversification in DNA-binding specificity? As these proteins evolved, did the intermediates in this process drastically switch DNA-binding specificity, or did they transit gradually through promiscuous states that recognized multiple DNA sequences? Among the many ways to evolve new biological innovations, gene duplication and neo-functionalization have been widely implicated as major forces in evolution ([@bib9]; [@bib25]; [@bib37]; [@bib51]; [@bib63]). In this process, after a gene was duplicated, one copy retained the original function, whereas the other accumulated beneficial and diverging mutations that produced a different protein with a new function. In the case of DNA-binding proteins, a new function could be the recognition of an entirely different DNA site. In this work, we used a pair of related DNA-binding proteins (ParB \[Partitioning Protein B\] and Noc \[Nucleoid Occlusion Factor\]) that are crucial for bacterial chromosome segregation and maintenance to better understand factors that might have influenced the evolution of a new DNA-binding specificity.

ParB is important for faithful chromosome segregation in two-thirds of bacterial species ([@bib35]; [@bib36]). The centromere-like *parS* DNA locus is the first to be segregated following chromosome replication ([@bib29]; [@bib34]; [@bib35]; [@bib36]; [@bib64]). *parS* is bound by ParB, which in turn interacts with ParA and SMC proteins to partition the ParB-*parS* nucleoprotein complex and, hence the chromosome, into each daughter cell ([@bib16]; [@bib17]; [@bib19]; [@bib21]; [@bib35]; [@bib42]; [@bib65], [@bib66]; [@bib69]; [Figure 1](#fig1){ref-type="fig"}A). ParB specifically recognizes and binds to *parS*, a palindromic sequence ([Figure 1](#fig1){ref-type="fig"}A) that can be present as multiple copies on the bacterial chromosome but is almost always located close to the origin of replication (*oriC*) on each chromosome ([Figure 1](#fig1){ref-type="fig"}A; [@bib20]; [@bib24]; [@bib27]; [@bib29]; [@bib35]; [@bib36]; [@bib43]; [@bib66]). ParB proteins are widely distributed in bacteria and so must have appeared early in evolution ([Figure 1](#fig1){ref-type="fig"}B; [@bib36]).Figure 1DNA-Binding Specificity for *parS* and *NBS* Is Conserved among ParB and Noc Orthologs(A) The domain architecture of ParB (dark green) and Noc (magenta) together with their respective cognate DNA-binding sites *parS* and *NBS*. Sequence differences between *parS* and *NBS* are highlighted (*parS*, dark green; *NBS*, magenta). The genome-wide distributions of *parS* and *NBS* sites (dark green and magenta circles, respectively) are also shown schematically.(B) An unrooted maximum likelihood tree that shows the restrictive distribution of Noc orthologs (magenta branches) to the Firmicutes clade. Bootstrap support values are shown for branches.(C) The *in vivo* binding preferences of ParB/Noc to *parS*/*NBS*, as measured by ChIP-qPCR. Error bars represent standard deviation (SD) from three replicates. An *E. coli* strain with a single *parS* and *NBS* site engineered onto the chromosome was used as a heterologous host for the expression of FLAG-tagged ParB/Noc.

Noc, a ParB-related protein, was first discovered in *Bacillus subtilis* ([@bib56]; [@bib72]). Like ParB, Noc has a three-domain architecture: an N-terminal domain for protein-protein interactions and for targeting Noc to the cell membrane, a central DNA-binding domain (DBD), and a C-terminal dimerization domain ([@bib72]; [@bib74]; [Figure 1](#fig1){ref-type="fig"}A). In contrast to ParB, Noc recognizes a DNA-binding sequence called *NBS* (Noc Binding Site) ([@bib47]; [@bib74]; [Figure 1](#fig1){ref-type="fig"}A). The role of Noc is also different from ParB; Noc functions to prevent the cell division machinery from assembling in the vicinity of the nucleoid, which might be otherwise guillotined, thereby damaging the DNA ([@bib72]; [@bib74]: [Figure 1](#fig1){ref-type="fig"}B). In other words, Noc has a role in preserving the integrity of the chromosome. The genome-wide distribution of *NBS* is also drastically different from that of *parS*. Although *parS* sites are restricted in the region around *oriC*, *NBS* distributes widely on the genome, except near the terminus of replication (*ter*) ([@bib47]; [@bib74]). The absence of *NBS* near *ter* is crucial to direct the formation of the FtsZ ring and cell division to mid-cell ([Figure 1](#fig1){ref-type="fig"}A). Because of their genomic proximity ([Figure S1](#mmc1){ref-type="supplementary-material"}) and high sequence similarity, it was suggested that *noc* resulted from a gene duplication event from *parB* ([@bib56]; [@bib73]). A phylogenetic tree showed that *parB* genes are widely distributed in bacteria but *noc* genes are confined to the Firmicutes clade ([@bib73]; [Figure 1](#fig1){ref-type="fig"}B). This phylogenetic distribution is most consistent with *parB* appearing early in evolution, possibly before the split between Gram-positive and Gram-negative bacteria, and that the occurrence of *noc* is a later event that happened only in Firmicutes ([@bib73]).

Here, we systematically measure the binding preferences of 17 ParB and 4 Noc family members to *parS* and *NBS* and find that their interactions are specific and conserved among bacterial species. We show that specificity to *parS* or *NBS* is encoded by a small set of four residues at the protein-DNA interface and that mutations in these residues are enough to reprogram DNA-binding specificity. Combining X-ray crystallography and systematic scanning mutagenesis, we show that both permissive and specificity-switching substitutions are required to acquire a new DNA-binding specificity. Guided by these findings, we generate a saturated library with \~10^5^ variants of the specificity-defining residues in ParB and select for mutants that bind to *parS* or *NBS* or both. We discover multiple alternative combinations of residues that are capable of binding to *parS* or *NBS*. By analyzing the connectivity of functional variants in the sequence space, we suggest that permissive and specificity-switching mutations, at least when considering the four mutations in this work, must be introduced in an orderly manner to evolve a new protein-DNA interface.

Results {#sec2}
=======

DNA-Binding Specificity for *parS* and *NBS* Is Conserved within ParB and Noc Family {#sec2.1}
------------------------------------------------------------------------------------

To test whether ParB and Noc family members retained their DNA-binding specificity, we selected a group of 17 ParB and 4 Noc from various bacterial clades for characterization ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}A). ParB or Noc proteins were expressed individually in *Escherichia coli* and were engineered with an N-terminal FLAG tag for immunoprecipitation. We performed chromatin immunoprecipitation (ChIP)-qPCR and ChIP sequencing (ChIP-seq) experiments to quantify the level of ParB or Noc that are bound at a single *parS* or *NBS* site engineered onto the *E. coli* chromosome ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}B). *E. coli* is a perfect heterologous host for this experiment, as it does not possess native ParB/Noc homologs and there are no *parS*/*NBS* sites in its genome. As shown in [Figure 1](#fig1){ref-type="fig"}C, all tested ParB proteins bind preferentially to *parS* over *NBS*, whereas Noc proteins prefer *NBS* to *parS*. This conservation of DNA preference suggests that there exists a set of conserved residues within each protein family (ParB or Noc) that dictates specificity.

The Co-crystal Structure of the DBD of ParB with *parS* Reveals Residues That Contact DNA {#sec2.2}
-----------------------------------------------------------------------------------------

As the first step in identifying specificity residues, we solved a 2.4-Å resolution co-crystal structure of the DBD of *Caulobacter crescentus* ParB bound to a 20-bp *parS* DNA duplex ([Figure 2](#fig2){ref-type="fig"}A). In the crystallographic asymmetric unit, two very similar ParB DBD monomers (root-mean-square deviation \[RMSD\] = 0.1 Å) bind in a 2-fold symmetric fashion to a full-size *parS* DNA duplex ([Figure 2](#fig2){ref-type="fig"}A). This structure reveals several regions of each DBD that contact *parS* ([Figure 2](#fig2){ref-type="fig"}B). First, the recognition helix α4 of the helix-turn-helix motif inserts into the major grooves of the palindromic *parS* site ([Figure 2](#fig2){ref-type="fig"}B). Second, helices α6 and α8 contribute residues to the protein-DNA interface ([Figure 2](#fig2){ref-type="fig"}B). Last, several lysine and arginine residues in the loop spanning residues 236--254 contact the minor groove side of *parS* in an adjacent complex in the crystal ([Figure 2](#fig2){ref-type="fig"}A). From the structure of the complex, we identified residues that make specific contacts with the DNA bases as well as non-specific contacts with the phosphate backbone ([Figure 2](#fig2){ref-type="fig"}C). We verified the protein-DNA contacts by individually mutating each residue to alanine ([Figure 2](#fig2){ref-type="fig"}D). We found that most of the crucial residues for binding to *parS* are within the 162--234 region ([Figure 2](#fig2){ref-type="fig"}D), suggesting their importance in recognizing DNA specifically. We reasoned that specificity residues for *parS* (and *NBS*) must localize within this amino acid (aa) region in ParB (and in an equivalent region in Noc).Figure 2Co-crystal Structure of the DBD of *Caulobacter* ParB with *parS*(A) The 2.4-Å resolution structure of two ParB (DBD) monomers (dark green) in complex with a 20-bp *parS* DNA (gray). The nucleotide sequence of the 20-bp *parS* is shown below the structure; bases (guanine 1 and adenine 6) that are different from *NBS* are in bold. The purification tag is also visible in one of the DBD monomers. Loop (236--254) contacts the adjacent DNA in the crystal lattice.(B) One monomer of ParB (DBD) is shown in complex with a *parS* half-site; residues that contact the DNA are labeled and colored in orange.(C) Schematic representation of ParB (DBD)-*parS* interactions. For simplicity, only a *parS* half-site is shown. The two bases at position 1 and 6 that are different between *parS* and *NBS* are highlighted in dark green.(D) Alanine scanning mutagenesis and the *in vitro* dissociation constant (K~D~) ± standard deviation (SD) of ParB variants to *parS* DNA. See also [STAR Methods](#sec4){ref-type="sec"} for details on curve fitting and calculation of SD values.

Mutations at Four Residues at the ParB-*parS* Interface Are Sufficient to Reprogram DNA-Binding Specificity toward *NBS* {#sec2.3}
------------------------------------------------------------------------------------------------------------------------

To discover the region of Noc that determines the specificity for *NBS*, we constructed a series of chimeric proteins in which different regions of *Caulobacter* ParB were replaced with the corresponding regions of *B. subtilis* Noc ([Figure 3](#fig3){ref-type="fig"}A). Replacing the entire region (residues 162--230) containing the helix-turn-helix motif, helix α6, and part of helix α8 with the corresponding region of *B. subtilis* Noc produced a chimera that binds to both *parS* and *NBS*, but with a preference for *NBS* (Chimera 1; [Figure 3](#fig3){ref-type="fig"}A). Swapping a smaller region (residues 162--207) containing just the helix-turn-helix motif and an adjacent helix α6 created a chimera that has an improved specificity for *NBS*, albeit with a lower binding affinity (Chimera 4; [Figure 3](#fig3){ref-type="fig"}A). These results suggest that the region (residues 162--207) might contain the core set of specificity residues for *NBS*.Figure 3Mutations at Four Residues at the ParB-*parS* Interface Are Sufficient to Reprogram DNA-Binding Specificity Toward *NBS*(A) Mutations in a subset of residues in the region between residues 162--207 (ParB's numbering) can reprogram interaction specificity. ParB (or segments of amino acids \[aas\] from ParB) and Noc (or the equivalent segment in Noc) are shown in dark green and magenta, respectively. The affinity of protein-DNA interaction was expressed as dissociation constant (K~D~) ± standard deviation (SD). See also STAR Methods for details on curve fitting and calculation of SD values.(B) The sequence alignment of ParB (\~1,800 sequences) and Noc (\~400 sequences) orthologs. The aas are colored based on their chemical properties (GSTYC, polar; QN, neutral; KRH, basic; DE, acidic; and AVLIPWFM, hydrophobic). The secondary structure of the aa region (residues 162--207) is shown above the sequence alignment, together with residues (open circles) that contact DNA in the ParB (DBD)-*parS* structure ([Figure 2](#fig2){ref-type="fig"}).(C) Systematic scanning mutagenesis of the protein-DNA interface reveals the contribution of each specificity residue to the DNA-binding preference. Interactions between ParB + 15 PtoN intermediates with 16 DNA sites are represented as a heatmap in which each matrix position reflects a K~D~ value. The aa residues/bases from ParB/*parS* are colored in dark green, and those from Noc/*NBS* in magenta.(D) A hierarchical clustering of data in (C) in both protein and DNA dimensions.(E) A simplified heatmap in which only PtoN intermediates with a glutamine (Q) at position 173 are shown.(F) A simplified heatmap in which only PtoN intermediates with an arginine (R) at position 201 are shown.

To better understand the high degree of specificity conserved within the ParB and Noc families, we mapped a sequence alignment of \~1,800 ParB and \~400 Noc orthologs onto the ParB (DBD)-*parS* crystal structure to determine aa sequence preferences for those residues required for interaction specificity ([Figure 3](#fig3){ref-type="fig"}B). We focused our attention on the region between residues 162 and 207, which was shown above to contain the core specificity residues ([Figure 3](#fig3){ref-type="fig"}B). Of those residues that contact *parS* ([Figures 2](#fig2){ref-type="fig"}B and 2C), six residues (Q162, G170, K171, S172, N178, and R204) are conserved between ParB and Noc family members ([Figure 3](#fig3){ref-type="fig"}B). Two residues (R173 and G201) in ParB contact *parS* but are changed to Q173 and R201, respectively, in Noc homologs ([Figure 3](#fig3){ref-type="fig"}B). Other residues at positions 179 and 184 vary among ParB homologs but are almost invariably a lysine in Noc family members ([Figure 3](#fig3){ref-type="fig"}B). We hypothesized that these residues (Q173, K179, K184, and R201) ([Figure 3](#fig3){ref-type="fig"}B) are specificity residues that dictate Noc preference for *NBS*. To test this hypothesis, we generated a variant of *Caulobacter* ParB in which these four residues were introduced at the structurally equivalent positions (R173Q, T179K, A184K, and G201R). We purified and tested this variant in a bio-layer interferometry assay with *parS* and *NBS*. As shown in [Figure 3](#fig3){ref-type="fig"}A, a ParB (RTAG→QKKR) (PtoN15) variant completely switched its binding preference to a non-cognate *NBS* site. Hence, a core set of four residues are enough to reprogram specificity.

Systematic Dissection of ParB-*parS* and Noc-*NBS* Interfaces Reveals the Contribution of Each Specificity Residue to the DNA-Binding Preference {#sec2.4}
------------------------------------------------------------------------------------------------------------------------------------------------

To systematically dissect the role of each specificity residue, we constructed a complete set of ParB mutants that have either single, double, or triple aa changes between the four specificity positions, from a *parS*-preferred *Caulobacter* ParB (R^173^T^179^A^184^G^201^) to an *NBS*-preferred variant (Q^173^K^179^K^184^R^201^). We named them ParB-to-Noc intermediates (PtoN; 15 variants in total). To simplify the nomenclature, we named the mutants based on the specificity residues being considered, for example, an *NBS*-preferred variant (Q^173^K^179^K^184^R^201^) is shortened to PtoN15 (QKKR). ParB and 15 PtoN variants were purified and tested with a series of 16 different DNA sites, each representing a transitional state from *parS* to *NBS*, with each of the 2 variable positions (1 and 6) changed to any of other 4 DNA bases ([Figure 3](#fig3){ref-type="fig"}C). We visualized 16 × 16 interactions as a heatmap where each matrix position reflects a dissociation constant (K~D~).

This systematic pairwise interaction screen led to several notable observations ([Figure 3](#fig3){ref-type="fig"}C). First, there are 2 non-functional variants (PtoN1: QTAG and PtoN7: QTAR) that were unable to interact with any of the 16 DNA sites ([Figure 3](#fig3){ref-type="fig"}C). Second, six variants (PtoN4: RTAR, PtoN5: QKAG, PtoN6: QTKG, PtoN9: RKAR, PtoN10: RTKR, and PtoN11: QKKG) switched their specificity to a DNA site that has features borrowed from both *parS* and *NBS*. Meanwhile, four variants (PtoN2: RKAG, PtoN3: RTKG, PtoN8: RKKG, and PtoN14: RKKR) were promiscuous, i.e., binding to multiple different DNA sites ([Figure 3](#fig3){ref-type="fig"}C). We noted that functional PtoN variants have a lysine at either position 179 or 184 or both. This observation became even clearer after we performed hierarchical clustering of the interaction profile in both the protein and the DNA dimensions ([Figure 3](#fig3){ref-type="fig"}D). A single lysine at either position 179 or 184 is enough to license the DNA-binding capability to PtoN variants (nodes a, b, d, and f on the clustering tree; [Figure 3](#fig3){ref-type="fig"}D), whereas PtoN1 (QTAG) and PtoN7 (QTAR) that do not possess any lysine at 179/184 are non-functional (node e; [Figure 3](#fig3){ref-type="fig"}D). We suggest that K179/184 has a permissive effect that might permit Q173 and R201 to contact DNA.

Next, we wondered which base of the *NBS* site that Q173 might contact specifically. To find out, we clustered only PtoN variants that share the Q aa at position 173 ([Figure 3](#fig3){ref-type="fig"}E). We discovered that those variants preferred DNA sites that possess an adenine at position 1 ([Figure 3](#fig3){ref-type="fig"}E). We applied the same approach to find the base that residue R201 might contact ([Figure 3](#fig3){ref-type="fig"}F). The emerging trend is that PtoN variants that share an R aa at 201 preferred DNA sites with a cytosine at position 6 ([Figure 3](#fig3){ref-type="fig"}F). Taken together, our results suggest a model in which each specificity residue has a distinct role, namely, Q173 recognizes adenine 1 and R201 recognizes cytosine 6, but they can only do so in the presence of a permissive K at either position 179 or 184 or both. In the next section, we used X-ray crystallography to provide evidence to support this model.

Co-crystal Structure of the DBD of Noc with *NBS* Reveals the Contribution of Specificity Residues to the DNA-Binding Preference {#sec2.5}
--------------------------------------------------------------------------------------------------------------------------------

To understand the biophysical mechanism underlying the specificity to *NBS*, we solved the co-crystal structure of *B. subtilis* Noc (DBD) with a 22-bp *NBS* DNA duplex ([Figure S2](#mmc1){ref-type="supplementary-material"}). The diffraction of the Noc (DBD)-*NBS* crystal was anisotropic. Hence, despite the 2.23-Å resolution limit, because of low completeness in the higher resolution shells resulting from the anisotropic cutoff, the resultant electron density has the appearance of lower resolution maps, approximately a 3-Å resolution ([Table S4](#mmc1){ref-type="supplementary-material"}; [STAR Methods](#sec4){ref-type="sec"}). By superimposing the structures of ParB (DBD)-*parS* and Noc (DBD)-*NBS* complexes, we observed several changes in both the protein and the DNA sites that enabled specific interactions ([Figure 4](#fig4){ref-type="fig"}). First, R173 in ParB hydrogen bonds with *parS* guanine 1, but the shorter side chain of a corresponding Q158 in Noc is unable to bond with guanine 1 ([Figure 4](#fig4){ref-type="fig"}A). However, a corresponding base in *NBS* (adenine 1) positions itself closer to enable hydrogen bonding with this Q173 residue ([Figure 4](#fig4){ref-type="fig"}A); this is possibly due to conformational changes in the *NBS* site that narrows the minor groove width at the adenine 1:thymine −1 position (from \~7.7 to \~3.7 Å; [Figure S3](#mmc1){ref-type="supplementary-material"}). The switch from R to Q serves to eliminate the ability of ParB to contact *parS* guanine 1 while simultaneously establishing a new contact with *NBS* adenine 1. The second notable changes between the two co-crystal structures occurs at position 201 ([Figure 4](#fig4){ref-type="fig"}B). G201 from ParB has no side chain and hence cannot contact thymine −6 specifically ([Figure 4](#fig4){ref-type="fig"}B). However, the equivalent residue R186 in Noc readily forms hydrogen bonds with guanine −6 ([Figure 4](#fig4){ref-type="fig"}B). We also observed DNA unwinding that increased both the minor and the major groove widths at the cytosine 6:guanine −6 position of *NBS* (from \~7.1 to \~8.1 Å and from \~10.5 to \~11.8 Å, respectively), possibly to move guanine −6 outward to accommodate a longer side chain of arginine ([Figure S3](#mmc1){ref-type="supplementary-material"}). The NH group in the main chain of both G201 (ParB (DBD)-*parS* structure) and R186 (Noc(DBD)-*NBS* structure) also contact DNA non-specifically by their interaction with the phosphate groups of thymine −6 (*parS*) and guanine −6 (*NBS*), respectively ([Figure 4](#fig4){ref-type="fig"}; see also [Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}D).Figure 4Superimposition of the ParB (DBD)-*parS* Structure on the Noc (DBD)-*NBS* Structure Reveals the Contribution of Specificity Residues to *NBS* BindingTo simplify and highlight the roles of specificity residues, only the side chains of specificity residues and their contacting bases are shown. The aa regions (173--207 in ParB and the corresponding 158--192 in Noc) and the DNA backbones are shown in the cartoon representation. DNA bases are numbered according to their respective positions on the *parS/NBS* site. The insets show interactions between either R173 (ParB's numbering) and Q158 (Noc's numbering) (A) or G201 (ParB's numbering) and R186 (Noc's numbering) (B) and with their corresponding bases on *parS/NBS*. The side chains of K164 and K169 in the Noc (DBD)-*NBS* structure contact the phosphate groups of guanine (−5) and thymine (2) of *NBS*, respectively (see also [Figure S2](#mmc1){ref-type="supplementary-material"}D). Only the phosphate groups of guanine (−5) and thymine (2) in *NBS* are shown.

Our Noc (DBD)-*NBS* structure also shows the side chains of K164 and K169 make hydrogen bonds with the phosphate groups of guanine −5 and thymine 2 of *NBS* rather than contacting any bases specifically ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Last, molecular dynamics simulations using the Noc (DBD)-*NBS* structure as initial coordinates also suggested that side chains of K164 and K169 make hydrogen bonds or salt bridges with the DNA backbone, especially when water-mediated contacts were also considered (bonding for \>99% of the whole simulation; see also [STAR Methods](#sec4){ref-type="sec"}). The most parsimonious explanation for the permissive capability of K164/169 is that they increase DNA-binding affinity non-specifically to overcome the initial energy barrier and permit specific base contacts from Q158 and R186. Overall, our co-crystal structures are consistent with data from the systematic scanning mutagenesis.

A High-Throughput Bacterial One-Hybrid Selection Reveals Multiple Combinations of Specificity Residues That Enable *parS* and *NBS* Recognition {#sec2.6}
-----------------------------------------------------------------------------------------------------------------------------------------------

Although the results from our systematic scanning mutagenesis and X-ray crystallography revealed how specificity changed as individual substitutions were introduced, presumably a greater variety of amino acids has been sampled by nature than those presented at the start (RTAG) and endpoint (QKKR). What are the paths, and are there many, to convert a *parS*-binding protein to an *NBS*-preferred one? Does the order of aa substitutions matter? To answer these questions, we explored the entire sequence space at the four specificity residues by generating a combinatorial library of ParB where positions 173, 179, 184, and 201 can be any aa (20^4^ or 160,000 variants lacking stop codons). We optimized a bacterial one-hybrid (B1H) assay ([@bib46]) that is based on transcriptional activation of an imidazoleglycerol-phosphate dehydratase encoding gene HIS3 to enable a selection for *parS* or *NBS*-binding variants ([Figure 5](#fig5){ref-type="fig"}A; [Figure S4](#mmc1){ref-type="supplementary-material"}). ParB variants were fused at their N termini to the omega subunit of bacterial RNA polymerase. NNS codons (where N = any nucleotide \[nt\] and S = cytosine or guanine) were used to randomize the four specificity residues. All ParB variants were also engineered to contain an additional invariable mutation in the N-terminal domain (R104A) that makes ParB unable to spread ([@bib32]; [@bib66]; [Figure 5](#fig5){ref-type="fig"}A). The R104A mutation does not affect the site-specific binding but enables a simpler design of the selection system by converting ParB to a conventional site-specific transcriptional activator ([Figure 5](#fig5){ref-type="fig"}A). If a ParB variant binds to a *parS* or *NBS* site engineered upstream of HIS3, it will recruit RNA polymerase to activate HIS3 expression, thereby enabling a histidine-auxotrophic *E. coli* host to survive on a minimal medium lacking histidine ([Figure 5](#fig5){ref-type="fig"}A; [Figure S4](#mmc1){ref-type="supplementary-material"}). Deep sequencing of starting libraries revealed that \>94% of the predicted variants were represented by at least 10 reads ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B) and that libraries prepared on different days were reproducible (*R*^*2*^ \> 0.90; [Figure S5](#mmc1){ref-type="supplementary-material"}C).Figure 5High-Throughput Mapping of the Fitness of Protein-DNA Interface Mutants(A) The principle and design of the deep mutational scanning experiment that was based on a bacterial one-hybrid assay and high-throughput sequencing.(B) Summary of functional *NBS*-binding and *parS*-binding variants.(C) Fitness scores of variants, as assessed by their ability to bind *NBS* (x axis) or *parS* (y axis). Dark green: strong *parS* binding, no *NBS* binding (fitness score: ƒ~*parS*~ ≥ 0.6, ƒ~*NBS*~ ≤ 0.2); light green: strong *parS* binding, weak-to-medium *NBS* binding (ƒ~*parS*~ ≥ 0.6, 0.2 ≤ ƒ~*NBS*~ ≤ 0.6); magenta: strong *NBS* binding, no *parS* binding (ƒ~*NBS*~ ≥ 0.6, ƒ~*parS*~ ≤ 0.2); pink: strong *NBS* binding, weak-to-medium *parS* binding (ƒ~*NBS*~ ≥ 0.6, 0.2 ≤ ƒ~*parS*~ ≤ 0.6); black: dual specificity (ƒ~*NBS*~ ≥ 0.6, ƒ~*parS*~ ≥ 0.6). Frequency logos of each class of variants are shown together with ones for ParB/Noc orthologs. The amino acids are colored according to their chemical properties. The positions of wild-type (WT) ParB (RTAG), Noc (QKKR), and nine selected variants for an independent validation are also shown and labeled on the scatterplot.

To assess the ability of each ParB variant to bind to *parS* or *NBS*, we deep sequenced the relevant region on *parB* variants pre- and post-selection to reveal the underlying sequences and their abundance ([Figure 5](#fig5){ref-type="fig"}A; [Figure S5](#mmc1){ref-type="supplementary-material"}C). As the strength of protein-DNA interaction is directly related to the amount of histidine being produced and ultimately to the cell fitness ([@bib46]), we quantified the fitness of each variant to rank them ([Figure 5](#fig5){ref-type="fig"}C). We found 1,385 and 362 variants that show strong binding to *parS* and *NBS*, respectively ([Figure 5](#fig5){ref-type="fig"}B). We then selected and verified nine variants that bind either *NBS* or *parS* or both ([Figure 5](#fig5){ref-type="fig"}C) by a pairwise B1H assay and by a bio-layer interferometry assay with purified proteins ([Figure S6](#mmc1){ref-type="supplementary-material"}). To systematically probe the sequence space, we generated a scatterplot of ParB variant fitness when screened for binding to *parS* or *NBS* ([Figure 5](#fig5){ref-type="fig"}C). Of 362 variants that bind *NBS* strongly, 261 are *NBS* specific (i.e., no *parS* binding, magenta box), 19 show strong *NBS* binding but weak-to-medium *parS* binding (pink box), and 82 dual-specificity variants that bind both *parS* and *NBS* (black box) ([Figure 5](#fig5){ref-type="fig"}C). By comparing sequence logos, we observed that *NBS*-specific variants (magenta box) have a high proportion of the Q residue at position 173 but R is allowed, position 201 is dominantly R but polar residues (T and S) are allowed, and positively charged R and K prevail at positions 179 and 184 ([Figure 5](#fig5){ref-type="fig"}C). This sequence logo shares some features with Noc orthologs (dashed magenta box, [Figure 5](#fig5){ref-type="fig"}C). On the other hand, *parS*-specific variants (dark green box) have an invariable R at position 173, which is the same as ParB orthologs (dashed dark green box) ([Figure 5](#fig5){ref-type="fig"}C), but position 201 can be small polar amino acids (C, S, or T, but G is most preferred). Notably, 17 amino acids (except the helix-breaking P or the negatively charged D and E) can occupy position 179, and any of the 20 amino acids is tolerable at position 184 ([Figure 5](#fig5){ref-type="fig"}C). Finally, dual-specificity variants (black box) tend to harbor sequence elements from both *parS*- and *NBS*-specific variants ([Figure 5](#fig5){ref-type="fig"}C).

*NBS*-Specific Variants Predominantly Have Lysine or Arginine at Positions 179 and 184 {#sec2.7}
--------------------------------------------------------------------------------------

The proportion of *NBS*-specific variants with a K or R aa at position 179 is \~58%, higher than a theoretical 10% value if K/R was chosen randomly ([Figure 6](#fig6){ref-type="fig"}A). The same proportion was seen for a K or R at position 184 ([Figure 6](#fig6){ref-type="fig"}A). This proportion increased to \~91% for *NBS*-specific variants with either K or R at either position 179 or 184 and \~19% for those with a K or R at both 179 and 184 ([Figure 6](#fig6){ref-type="fig"}A). The prevalence of positively charged residues, together with the structure of Noc (DBD)-*NBS*, supports our model that permissive mutations act by increasing protein-DNA binding affinity non-specifically by their interactions with a negatively charged phosphate backbone. We noted that K and R are not preferred more than expected from a random chance in *parS*-specific variants ([Figure 6](#fig6){ref-type="fig"}A). Our results suggest that the introduction of permissive substitutions is important to acquire a new specificity.Figure 6Deep Mutational Scanning Experiments Reveal the Common Properties of the Mutational Paths to a New DNA-Binding Specificity(A) Fractions of arginine or lysine residues at position 179 or 184 or both, in *parS*-specific (dark green) and *NBS*-specific (magenta) variants. The dotted lines indicate the expected percentage if arginine/lysine was chosen randomly from 20 amino acids.(B) A force-directed network graph connecting strong *parS*-binding variants to strong *NBS*-binding variants. Nodes represent individual variants, and edges represent single aa substitutions. Node sizes are proportional to their corresponding numbers of edges. Node colors correspond to different classes of variants.(C) Cumulative fraction of highly *parS*-specific variants that reached an *NBS*-specific QKKR variant in a given number of aa (solid line) or nt (dotted line) substitutions (see also [Figure S7](#mmc1){ref-type="supplementary-material"}A).(D) Fraction of intermediates on all shortest paths from highly *parS*-specific RXXG variants to the *NBS*-preferred QKKR that have permissive amino acids (K/R) at either position 179 or 184 or both or have R at position 201, or Q at position 173, or C/T/S at position 201 after a given number of aa steps (see also [Figure S7](#mmc1){ref-type="supplementary-material"}D).(E) Percentage of shortest paths that traversed black, light green, or pink variants to reach QKKR from any of the highly *parS*-specific RXXG variants (red lines). The result was compared to ones from 1,000 simulations where the edges were shuffled randomly while keeping the total number of nodes, edges, and graph density constant.

Mutations Were Introduced in a Defined Order to Reprogram Specificity {#sec2.8}
---------------------------------------------------------------------

We asked if there is an order of substitutions at positions 173, 179, 184, and 201 to create an *NBS*-specific variant. To answer this question, we first reconstructed all possible mutational paths to an *NBS* specificity. We created a force-directed graph that connects functional variants (nodes) together by lines (edges) if they are different by a single aa to visualize the connectivity of functional variants in sequence space ([Figure 6](#fig6){ref-type="fig"}B; [@bib48]). The node size is proportional to its connectivity (number of edges), and node colors represent different classes of functional variants ([Figure 6](#fig6){ref-type="fig"}B). Similarly, we also generated a network graph in which edges represent variants that differ by a single nt substitution ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). Because not all amino acids can be converted to others by a mutation at a single base, a by-nt-substitution network might depict better how long (hard) or short (easy) the mutational paths that *parS*-specific variants might have taken to reprogram their specificity to *NBS*. At first glance, the network is composed of multiple clusters of densely interconnected nodes that share common features in the aa sequence ([Figure 6](#fig6){ref-type="fig"}B). Furthermore, there are multiple edges connecting *parS*-preferred variants (dark and light green nodes) to *NBS*-preferred variants (magenta and pink nodes) ([Figure 6](#fig6){ref-type="fig"}B). Supporting this observation, we found that it takes at most four aa (or seven nt) substitutions to convert any *parS*-specific variant to an *NBS*-specific QKKR ([Figures 6](#fig6){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}C). A small number of steps suggested that *NBS*-specific variants can be reached relatively easily from *parS*-specific variants. We focused on *parS*-specific start point RXXG for all analyses below because R173 and G201 are absolutely conserved in all extant ParB orthologs ([Figure 5](#fig5){ref-type="fig"}C). We found all the shortest paths (1,232 in total) that connect *parS*-specific RXXG variants (298 dark green nodes) to an *NBS*-specific QKKR and quantified the fractions of intermediates in such paths that contain permissive or specificity-switching residues ([Figure 6](#fig6){ref-type="fig"}D). We discovered that permissive substitutions (K or R) at position 179 or 184 happened very early on along the mutational paths (\~95% after the first step; [Figure 6](#fig6){ref-type="fig"}D). The fraction of R201 increased more gradually after the introduction of permissive substitutions, and Q173 was introduced last ([Figure 6](#fig6){ref-type="fig"}D). The same order of substitutions was seen when we analyzed a by-nt-substitution network graph ([Figure S7](#mmc1){ref-type="supplementary-material"}D). In summary, we conclude that the order of aa substitutions matters and suggest that permissive mutations tend to happen before specificity-switching substitutions.

Mutational Paths That Reprogram Specificity Did Not Travel across Dual-Specificity Intermediates {#sec2.9}
------------------------------------------------------------------------------------------------

We observed that the fraction of variants with C/T/S residues at position 201 did not increase beyond 0% in any step from RXXG variants to QKKR ([Figures 6](#fig6){ref-type="fig"}D and [S7](#mmc1){ref-type="supplementary-material"}D). Given that dual-specificity variants (black box, [Figure 5](#fig5){ref-type="fig"}C) mostly have T or S aa at position 201, it suggests that dual-specificity intermediates might have not been exploited to change specificity. Indeed, no shortest path connecting RXXG and QKKR traversed any dual-specificity variant (black nodes) ([Figures 6](#fig6){ref-type="fig"}E and [S7](#mmc1){ref-type="supplementary-material"}E). This proportion is significantly smaller than would be expected by chance (estimated from 1,000 random networks where edges were shuffled randomly; [Figures 6](#fig6){ref-type="fig"}E and [S7](#mmc1){ref-type="supplementary-material"}E). In contrast, \~51% and \~3% of shortest paths from RXXG variants to QKKR contain light green and pink intermediates, respectively. The proportions of paths with light green or pink intermediates are similar to expected values from random chance ([Figure 6](#fig6){ref-type="fig"}E). The preference for traversing light green nodes, therefore, can be explained by the abundance of such variants in the observed graph ([Figure 6](#fig6){ref-type="fig"}B). Overall, our network analysis predicted that the *parS*-to-*NBS* reprogram did not exploit truly dual-specificity intermediates and that those with a stricter specificity (light green or pink) were more commonly used.

Discussion {#sec3}
==========

Determinants of Specificity and Implications for Understanding the Evolution of Protein-DNA Interfaces {#sec3.1}
------------------------------------------------------------------------------------------------------

The *NBS* site differs from the *parS* site by only 2 bases (positions 1 and 6; [Figure 1](#fig1){ref-type="fig"}A), but Noc and ParB recognize and bind them with exquisite specificity. We provided evidence that mutations must have been introduced in a defined order to reprogram specificity. Permissive substitutions (K/R at positions 179/184) tend to appear first, presumably to prime *parS*-specific variants for a subsequent introduction of specificity-switching residues (R201 and Q173) which would have otherwise rendered proteins non-functional ([Figure 7](#fig7){ref-type="fig"}). Supporting the priming role of permissive amino acids, we noted that \~28% of extant ParB already possess a lysine/arginine residue at position 184 ([Figure 5](#fig5){ref-type="fig"}C, a sequence logo in a dashed green box). An early introduction of permissive substitutions is likely to be a recurring principle of evolution. For example, a similar prerequisite for permissive mutations was observed in the evolution of influenza resistance to the antiviral drug oseltamivir ([@bib3]). Two permissive mutations were first acquired, allowing the virus to tolerate a subsequent occurrence of a H274Y mutation that weakened the binding of oseltamivir to the viral neuraminidase enzyme ([@bib3]). These permissive mutations improved the stability of neuraminidase before a structurally destabilizing H274Y substitution was introduced ([@bib3]; [@bib18]). Similarly, a permissive mutation that is far away from the active site of an antibiotic-degrading β-lactamase (TEM1) has little effect on its enzymatic activity by itself but restored stability loss by a subsequent mutation that increased TEM1 activity against cephalosporin antibiotics ([@bib68]). In another case, 11 permissive mutations were required to evolve an ancestral steroid hormone receptor from preferring an estrogen response element (ERE) to a new DNA sequence (steroid response element \[SRE\]) ([@bib40]). These 11 mutations were located outside the DNA-recognition motif but non-specifically increased the affinity for both ERE and SRE, thereby licensing three additional substitutions to alter the specificity to SRE ([@bib40]). Additionally, it has been shown that an early introduction of 11 permissive substitutions dramatically increased the number of SRE-binding variants well beyond the historically observed variants ([@bib61]). In our work, at least when considering just four aa residues, a single introduction of a lysine, either at position 179 or 184, was sufficient to permit Q173 and R201 to recognize *NBS* specifically.Figure 7A Model for the Evolution of *NBS*-Binding Specificity(A) Contributions of each specificity residue to enable a switch in binding specificity from *parS* to *NBS*. An R173Q substitution enabled interactions with adenine 1:thymine −1 (of *NBS*). A G201R substitution enabled interactions with cytosine 6: guanine −6 (of *NBS*). Q173 and R201 could only do so in the presence of permissive residues K at either 179 or 184 or both. Without K179/184, Q173 and R201 were poised to interact with specific bases but could not, possibly because of insufficient affinity for DNA.(B) Analysis of mutational paths that traversed the network of functional variants showed that the order of introducing specificity-switching substitutions matters and that the shortest paths to *NBS*-specific variants do not necessarily involve dual-specificity nodes to evolve a new DNA-binding preference.

Deep mutational scanning in conjunction with network analysis is a powerful approach to reconstruct possible mutational paths that might have been taken to acquire a new function ([@bib1]; [@bib48]; [@bib61]). Network graph theory was applied to understand the constraints on the evolution of protein-protein interfaces between a histidine kinase and its response regulator partner, between toxin and antitoxin pairs of proteins, and most recently to reveal the alternative evolutionary histories of a steroid hormone receptor ([@bib1]; [@bib48]; [@bib61]). In our case study, network analysis suggested that mutational paths to a new specificity did not necessarily have to visit dual-specificity intermediates, i.e., those that bind *parS* and *NBS* equally strongly ([Figure 6](#fig6){ref-type="fig"}E). Instead, mutational paths to an *NBS*-specific variant tend to be more switch-like, frequently visited dark green nodes (strong *parS* binding, no *NBS* binding) and light green nodes (strong *parS* binding, weak-to-medium *NBS* binding) ([Figures 5](#fig5){ref-type="fig"}C and [6](#fig6){ref-type="fig"}E). We reason that most black variants, albeit being dual specific, bind both *parS* and *NBS* at a slightly reduced affinity (compared to the wild-type *parS*-specific RTAG or *NBS*-specific QKKR variants; see the scatterplot on [Figure 5](#fig5){ref-type="fig"}C). This might have created an undesirable situation in which dual-specificity intermediates neither could compete with the original copy of ParB to bind *parS* nor had high enough affinity themselves to bind *NBS* sites, i.e., artificially made non-functional due to competition. A similar principle might also apply to other protein-DNA interactions throughout biology. For example, a reconstructed evolutionary history of a steroid hormone receptor indicated that an ancestral receptor (AncSR1) without permissive mutations must always pass through dual-specificity intermediates to acquire the present-day specificity. On the other hand, the presence of 11 permissive mutations (AncSR1+11P) eliminated the absolute requirement for these dual-specificity intermediates. More dramatically, it has been shown that a single substitution (i.e., a truly switch-like mechanism) was enough to reprogram the specificity of homologous repressor proteins (Arc and Mnt) in bacteriophage P22 ([@bib53]). Nevertheless, we noted that protein-protein interfaces, particularly in the case of paralogous toxin-antitoxin protein pairs, exploited extensively promiscuous intermediates to diversify and evolve instead. In the case of toxin-antitoxin systems, truly promiscuous intermediates might have been favored because many of them bound to and antagonized cognate and non-cognate toxins equally or even better than the wild type ([@bib1]). It is likely that the topology of the available sequence space and the biology of each system collectively influence the paths to evolve a new biological innovation.

In summary, our work provides a molecular basis for how protein-DNA interaction specificity can change, with a focus on chromosome maintenance proteins ParB/Noc and the minimal set of four specificity residues at their protein-DNA interfaces. A small number of specificity residues enabled a systematic analysis of the protein-DNA interface and possible mutational paths that could have changed specificity. In this regard, our work might be useful for understanding the evolution of other classes of DNA-binding proteins. Nevertheless, evolution has most likely exploited more mutations and aa residues to fine-tune DNA-binding specificity than the core set of four residues in this work. Other compensatory mutations that alter the structural stability of proteins might also contribute and dictate the course of evolution to new biological functions ([@bib23]; [@bib57]; [@bib60]). An important challenge for future work is to study all contributing factors (permissive, specificity-switching, and other compensatory substitutions) in a systematic manner to better understand the course of evolution to new biological innovations.
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Key Resources Table {#sec4.1}
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REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains**Please refer to [Table S1](#mmc1){ref-type="supplementary-material"}N/A**Chemicals, Peptides, and Recombinant Proteins**3-ATAbcamCat\# ab146281Benzonase nucleaseSigma-AldrichCat\# E1014cOmplete, Mini, EDTA-free Protease Inhibitor CocktailRoche Applied ScienceCat\# 11836170001**Critical Commercial Assays**Gibson Assembly Master MixNEBCat\# E2611SGateway BP Clonase II enzyme mixThermoFisherCat\# 11789020SYBR® Green JumpStart Taq ReadyMixSigma-AldrichCat\# S4438Dip-and-Read Streptavidin (SA) biosensorsMolecular DevicesCat\# 18-5019HisTrap High Performance columnGE HealthcareCat\# GE17524801HiTrap Heparin High Performance columnGE HealthcareCat\# GE17040601HiLoad 16/600 Superdex 75pg columnGE HealthcareCat\# GE28989333HIS-Select Cobalt Affinity GelSigma-AldrichCat\# H8162PD 10 Desalting ColumnsSigma-AldrichCat\# GE17085101EZview Red ANTI-FLAG® M2 Affinity GelSigma-AldrichCat\# F2426; RRID: [AB_2616449](nif-antibody:AB_2616449){#interref165}QIAquick PCR Purification KitQIAGENCat\# 28104NEBNext Ultra DNA Library Prep Kit for IlluminaNEBCat\# E7370SQubit dsDNA HS Assay KitThermoFisherCat\# Q32851**Deposited Data**Crystal structuresThis paperPDB: [6S6H](pdb:6S6H){#intref0010}, [6Y93](pdb:6Y93){#intref0015}ChIP-seq dataThis paperGene Expression Omnibus: [GSE129285](ncbi-geo:GSE129285){#interref170}B1H-seq dataThis paperGene Expression Omnibus: [GSE129285](ncbi-geo:GSE129285){#interref175}Other dataThis paperMendeley Data: [https://doi.org/10.17632/8v45kvdtw5.1](10.17632/8v45kvdtw5.1){#intref0020}**Recombinant DNA**Please refer to [Table S2](#mmc1){ref-type="supplementary-material"}N/A**Oligonucleotides**Please refer to [Table S3](#mmc1){ref-type="supplementary-material"}N/A**Software and Algorithms**BLItz ProMolecular DevicesCat\# 50-0156GephiThe Open Graph Viz Platform<https://gephi.org/>RR Foundation for Statistical Computing<https://www.r-project.org/>igraphIgraph-The network analysis package<https://igraph.org/>HHsuite[@bib62]<https://github.com/soedinglab/hh-suite>WebLogo 3.0[@bib11]<http://weblogo.threeplusone.com/>iTOL[@bib33]<https://itol.embl.de/>CIPRES[@bib41]<http://www.phylo.org/>Curves+[@bib31]<http://curvesplus.bsc.es/analyse>Bowtie 1[@bib30]<http://bowtie-bio.sourceforge.net/index.shtml>BEDTools[@bib52]<https://bedtools.readthedocs.io/en/latest/>FASTX-ToolkitHannon Lab<http://hannonlab.cshl.edu/fastx_toolkit/>DIALS[@bib71]<https://dials.github.io/>AIMLESS[@bib15]<http://www.ccp4.ac.uk/html/aimless.html>CCP4i2[@bib49]<http://www.ccp4.ac.uk/>COOT[@bib14]<https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>PHASER[@bib39]<https://www.phenix-online.org/>REFMAC5[@bib44]<http://www.ccp4.ac.uk/html/refmac5/description.html>BUCCANEER[@bib10]<http://www.ccp4.ac.uk/html/cbuccaneer.html>MolProbity[@bib6]<http://molprobity.biochem.duke.edu/>STARANISOGlobal Phasing Limited<http://staraniso.globalphasing.org/cgi-bin/staraniso.cgi>jsPISA[@bib28]<http://www.ccp4.ac.uk/pisa/>PyMOLThe PyMOL Molecular Graphics System<https://pymol.org/2/>AMBERAMBER Software, University of California, San Francisco<https://ambermd.org/>

Resources Availability {#sec4.2}
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### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Tung Le (<tung.le@jic.ac.uk>).

### Materials Availability {#sec4.2.2}

Plasmids and strains used in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

### Data and Code Availability {#sec4.2.3}

The accession number for the sequencing data reported in this paper is [GSE129285](ncbi-geo:GSE129285){#intref0145}. Atomic coordinates for protein crystal structures reported in this paper were deposited in the RCSB Protein Data Bank with the following accession numbers: 6S6H and 6Y93. Original data have been deposited to Mendeley Data ([https://doi.org/10.17632/8v45kvdtw5.1](10.17632/8v45kvdtw5.1){#intref0150}).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Bacterial models {#sec4.3.1}

*Escherichia coli* strains DH5α and Rosetta (DE3) were used as hosts for constructing plasmids, and overexpression of proteins, respectively ([Table S1](#mmc1){ref-type="supplementary-material"}). *E. coli* USO *rpoZ*^*-*^ *hisB*^*-*^ *pyrF*^*-*^ was used as a host for B1H assay ([Table S1](#mmc1){ref-type="supplementary-material"}).

### Growth conditions {#sec4.3.2}

*E. coli* was grown in LB. When appropriate, media were supplemented with antibiotics at the following concentrations (liquid/solid media for *E. coli* (μg/mL): carbenicillin (50/100), chloramphenicol (20/30), kanamycin (30/50), and apramycin (25/50).

### Plasmids and strains construction {#sec4.3.3}

All strains used are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. All plasmids and primers used in strain and plasmid construction are listed in [Tables S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

*pENTR::Noc/ParB*. The coding sequences of ParB and Noc from various bacterial species ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}A) were chemically synthesized (gBlocks dsDNA fragments, IDT). The backbone of pENTR plasmid was amplified by PCR using primers pENTR_gibson_backbone_F and pENTR_gibson_backbone_R from the pENTR-D-TOPO cloning kit (Invitrogen). The resulting PCR product was subsequently treated with DpnI to remove methylated template DNA. The resulting PCR fragment was gel-purified and assembled with the gBlocks fragment using a 2x Gibson master mix (NEB). Gibson assembly was possible due to a 23 bp sequence shared between the PCR fragment and the gBlocks fragment. These 23 bp regions were incorporated during the synthesis of gBlocks fragments. The resulting plasmids were sequence verified by Sanger sequencing (Eurofins, Germany).

*pUT18C-1xFLAG-DEST*. The backbone of pUT18C was amplified using primers P1936 and P1937, and pUT18C ([@bib26]) as template. The resulting PCR product was subsequently treated with DpnI to remove the methylated template DNA. The FLAG-*attR1*-*ccdB*-chloramphenicol^R^-*attR2* cassette was amplified using primers P1934 and P1935, and pML477 as template. The two PCR fragments were each gel-purified and assembled together using a 2x Gibson master mix (NEB). Gibson assembly was possible due to a 23 bp sequence shared between the two PCR fragments. These 23 bp regions were incorporated during the primer design to amplify the FLAG-*attR1*-*ccdB*-chloramphenicol^R^-*attR2* cassette. The resulting plasmid was sequence verified by Sanger sequencing (Eurofins, Germany).

*pUT18C::1xFLAG-Noc/ParB*. The *parB*/*noc* genes were recombined into a Gateway-compatible destination vector pUT18C-1xFLAG-DEST via a LR recombination reaction (Invitrogen). For LR recombination reactions: 1 μL of purified pENTR::*parB/noc* was incubated with 1 μL of the destination vector pUT18-1xFLAG-DEST, 1 μL of LR Clonase II master mix, and 2 μL of water in a total volume of 5 μL. The reaction was incubated for an hour at room temperature before being introduced to DH5α *E. coli* cells by heat-shock transformation. Cells were then plated out on LB agar + carbenicillin. Resulting colonies were restruck onto LB agar + carbenicillin and LB agar + kanamycin. Only colonies that survived on LB + carbenicillin plates were subsequently used for culturing and plasmid extraction.

*pB1H2-w2::*Caulobacter *ParB (R104A + Q173K179K184R201) and pB1H2-w2::*Caulobacter *ParB (R104A + R173A179T184G201)*. The coding sequence of *Caulobacter* ParB with the desired mutations was chemically synthesized (gBlocks dsDNA fragments, IDT). The pB1H2-w2 plasmid backbone was generated via a double digestion of pB1H2-w2::Prd plasmid ([@bib46]) with KpnI and XbaI. The resulting backbone was subsequently gel-purified and assembled with the gBlocks fragments using a 2x Gibson mastermix (NEB). Gibson assembly was possible due to a 23 bp sequence shared between the KpnI-XbaI-cut pB1H2-w2 backbone and the gBlocks fragment. These 23 bp regions were incorporated during the synthesis of gBlocks fragments. The resulting plasmids were sequence verified by Sanger sequencing (Eurofins, Germany).

*pB1H2-w5::*Caulobacter *ParB (R104A + Q173K179K184R201)*. The same procedure as above was used to generate this plasmid, except that pB1H2-w5::Prd plasmid ([@bib46]) was used.

*pB1H2-w5L::*Caulobacter *ParB (R104A + Q173K179K184R201)*. The same procedure as above was used to generate this plasmid, except that pB1H2-w5L::Prd plasmid ([@bib46]) was used.

*pU3H3::7/14/19/24bp-*NBS. The pU3H3 backbone was generated via a double digestion of pU3H3::MCS plasmid ([@bib46]) with XmaI and EcoRI. The backbone was subsequently gel-purified before being ligated with the DNA insert in the next step. The DNA insert containing *NBS* site with an appropriate spacer (7, 14, 19, or 24 bp) were generated by annealing complementary oligos together ([Table S3](#mmc1){ref-type="supplementary-material"}). The DNA inserts were subsequently 5′ phosphorylated using T4 PNK (NEB), and ligated to the XmaI-EcoRI-cut pU3H3 backbone using T4 DNA ligase (NEB). The resulting plasmids were sequence verified by Sanger sequencing (Eurofins, Germany).

*pU3H3::19bp-*parS. The same procedure as above was used to generate the plasmid, except that primers *parS*\_anneal_19bp_spacer_F and *parS*\_anneal_19bp_spacer_R were used.

*pET21b::ParB (variants)-His*~*6*~. All sequences of ParB variants were designed in VectorNTI (ThermoFisher) and chemically synthesized as gBlocks dsDNA fragments (IDT). Individual gBlocks fragment and a NdeI-HindIII-digested pET21b backbone were asssembled using a 2x Gibson master mix (NEB). Gibson assembly was possible due to a 23-bp sequence shared between the NdeI-HindIII-cut pET21b backbone and the gBlocks fragment. These 23-bp regions were incorporated during the synthesis of gBlocks fragments. The resulting plasmids were sequence verified by Sanger sequencing (Eurofins, Germany).

*Strains AB1157* ybbD*::*parS*::markerless* ygcE*::*NBS*::markerless*. We use Lambda Red to insert a cassette consisting of a *parS* site and an apramycin antibiotic resistance gene *aac(3)IV* at the *ybbD* locus on the *E. coli* AB1157 chromosome. The *parS*-FRT-apramycin^R^-FRT cassette was amplified by PCR using primers 1940 and 1941, and pIJ773 (a gift from Keith Chater) as template. These forward and reverse primers also carry a 39 bp homology to the left or the right of the insertion point at the *ybbD* locus. The resulting PCR products were gel-extracted and electroporated into an arabinose-induced *E. coli* AB1157/pKD46 cells. Colonies that formed on LB + apramycin was restruck on LB + apramycin and incubated at 42°C to cure the cells of pKD46 plasmid. Finally, the correct insertion of the *parS*-apramycin^R^ cassette was verified by PCR and Sanger sequencing. To remove the FRT- apramycin^R^-FRT region while leaving the *parS* site intact, a temperature sensitive FLP recombination plasmid pBT340 (a gift from Keith Chater) was subsequently introduced. To introduce the *NBS* site at the *ygcE* locus on the chromosome of *E. coli* AB1157 *ybbD*::*parS*::markerless, we employed the same procedure, except that the *NBS*-FRT-Apramycin^R^-FRT cassette was amplified by PCR using primer 3139 and 3140 instead.

Method Details {#sec4.4}
--------------

### Identification and alignment of ParB and Noc sequences {#sec4.4.1}

The sequences used for generating sequence conservation logos were retrieved and aligned using HHblits (-n 4 -e 1E-10 -maxfilt inf -neffmax 20 -nodiff -realign_max inf) and HHfilter (-id 100 -cov 75) in the HHsuite ([@bib62]), using *Caulobacter crescentus* ParB protein and *Bacillus subtilis* Noc protein sequences as queries. This procedure resulted in 1800 homologous ParB sequences and 361 homologous Noc sequences. The sequence conservation logos were generated by WebLogo 3.0 ([@bib11]), using ParB/Noc sequence alignments as input.

### Phylogenetic analysis of ParB and Noc protein sequences {#sec4.4.2}

Amino acid sequences of ParB and Noc from 21 selected bacterial species were retrieved by BLASTP and used to generate a phylogenetic tree ([Figure 1](#fig1){ref-type="fig"}B). Phylogenetic analyses were carried out using MUSCLE ([@bib13]) and RAxML ([@bib59]), which were used through the CIPRES science gateway ([@bib41]), and the trees were visualized using iTOL ([@bib33]). Amino acid sequences were aligned using MUSCLE with the following parameters: muscle -in infile.fasta -seqtype auto -maxiters 16 -maxmb 30000000 -log logfile.txt -weight1 clustalw -cluster1 upgmb -sueff 0.1 -root1 pseudo -maxtrees 1 -weight2 clustalw -cluster2 upgmb -sueff 0.1 -root2 pseudo -objscore sp -noanchors -phyiout outputi.phy

The resulting PHYLIP interleaved output file was then used to generate a maximum likelihood phylogenetic tree using RAxML-HPC BlackBox. The program was configured to perform rapid bootstrapping, followed by a maximum likelihood search to identify the best tree, with the following input parameters: raxmlHPC-HYBRID_8.2.10_comet -s infile.phy -N autoMRE -n result -f a -p 12345 -x 12345 -m PROTCATJTT

### Protein overexpression and purification {#sec4.4.3}

The DNA-binding domain (DBD) of *Caulobacter* ParB (residues 126-243) was expressed and purified as follows. Plasmid pET21b::*Caulobacter crescentus*-ParB-(His)~6~ (residue 126-243) was introduced into *E. coli* Rosetta (DE3) competent cells (Merck) by heat-shock transformation. 10 mL overnight culture was used to inoculate 4 L LB medium + carbenicillin + chloramphenicol. Cells were grown at 37°C with shaking at 210 rpm to an OD~600~ of \~0.4. The culture was then left to cool to 28°C before isopropyl-β-D-thiogalactopyranoside (IPTG) was added at a final concentration of 1.0 mM. The culture was left shaking for an additional 3 hours at 28°C before cells were harvested by centrifugation.

Pelleted cells were resuspended in a buffer containing 100 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM Imidazole, 5% (v/v) glycerol, 1 μL of Benzonase nuclease (Sigma Aldrich), 1 mg of lysozyme (Sigma Aldrich), and an EDTA-free protease inhibitor tablet (Roche). The pelleted cells were then lyzed by sonification (10 cycles of 15 s with 10 s resting on ice in between each cycle). The cell debris was removed though centrifugation at 28,000 g for 30 min and the supernatant was filtered through a 0.45 μm sterile filter. The protein was then loaded into a 1-mL HiTrap column (GE Healthcare) that had been equilibrated with buffer A \[100 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM Imidazole, and 5% glycerol\]. Protein was eluted from the column using an increasing (10 mM to 500 mM) imidazole gradient in the same buffer. ParB (DBD)-containing fractions were pooled and diluted to a conductivity of 16 mS/cm before being loaded onto a Heparin HP column (GE Healthcare) that had been equilibrated with 100 mM Tris-HCl pH 8.0, 25 mM NaCl, and 5% glycerol. Protein was eluted from the Heparin column using an increasing (25 mM to 1 M NaCl) salt gradient in the same buffer. ParB (DBD) fractions were pooled and analyzed for purity by SDS-PAGE. Glycerol was then added to ParB fractions to a final volume of 10%, followed by 10 mM EDTA and 1 mM DDT. The purified ParB (DBD) was subsequently aliquoted, snap frozen in liquid nitrogen, and stored at −80°C. ParB (DBD) that was used for X-ray crystallography was further polished via a gel-filtration column. To do so, purified ParB (DBD) was concentrated by centrifugation in an Amicon Ultra-15 3-kDa cut-off spin filters (Merck) before being loaded into a Superdex 75 gel filtration column (GE Healthcare). The gel filtration column was pre-equilibrated with 10 mM Tris-HCl pH 8.0 and 250 mM NaCl. ParB (DBD) fractions was then pooled and analyzed for purity by SDS-PAGE.

The DNA-binding domain (DBD) of *Bacillus subtillis* Noc-(His)~6~ (residue 111-242) was purified using the same 3-column procedure as above. All other ParB/Noc variants were purified using HIS-Select® Cobalt gravity flow columns as follows. Plasmid pET21b::*parB/noc* variants were introduced individually into *E. coli* Rosetta (DE3) competent cells (Merck) by heat-shock transformation. 10 mL overnight culture was used to inoculate 1 L LB medium + carbenicillin + chloramphenicol. Cells were grown at 37°C with shaking at 210 rpm to an OD~600~ of \~0.4. The culture was then left to cool to 28°C before IPTG was added to a final concentration of 0.5 mM. The culture was left shaking for an additional 3 hours at 30°C before cells were harvested by centrifugation. Pelleted cells were resuspended in 25 mL of buffer A \[100 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM Imidazole, 5% (v/v) glycerol\] containing 1 mg lysozyme (Sigma Aldrich), and an EDTA-free protease inhibitor tablet (Roche). The pelleted cells were then lyzed by sonification. The cell debris was removed though centrifugation at 28,000 g for 30 min and the supernatant was transferred to a gravity flow column containing 2 mL of HIS-Select® Cobalt Affinity Gel (Sigma Aldrich) that was pre-equilibrated with 40 mL of buffer A. The column was rotated at 4°C for 1 hour to allow for binding to His-tagged proteins to the resin. After the binding step, unbound proteins were washed off using 60 mL of buffer A. Proteins were eluted using 2.7 mL of buffer B \[100 mM Tris-HCl pH 8.0, 300 mM NaCl, 500 mM Imidazole, 5% (v/v) glycerol\]. The purified protein was desalted using a PD-10 column (GE Healthcare), concentrated using an Amicon Ultra-4 10 kDa cut-off spin column (Merck), and stored at −80°C in a storage buffer \[100 mM Tris-HCl pH 8.0, 300 mM NaCl, and 10% (v/v) glycerol\].

### Selection of *parS* and *NBS* site {#sec4.4.5}

For all experiments described in this work, we employed a consensus *parS* site (TGTTTCAC-GTGAAACA) and consensus *NBS* site (TATTTCCC-GGGAAATA) i.e., the idealized sequence that represents the predominant base at each position. The full position weight matrix (PWM) logos for *parS* and *NBS* sites have been described previously ([@bib36]; [@bib74]).

### Reconstitution of *parS* DNA for X-ray crystallography {#sec4.4.6}

A 20-bp palindromic DNA fragment (5′-GAT[GTTTCACGTGAAAC]{.ul}ATC-3′) (3.6 mM in buffer that contains 10 mM Tris-HCl pH 8.0 and 250 mM NaCl) was heated to 95°C for 5 min before being left to cool at room temperature overnight to form a double stranded *parS* DNA (final concentration: 1.8 mM). The 14-bp *parS* site sequences are underlined.

### Reconstitution of *NBS* DNA for X-ray crystallography {#sec4.4.7}

A 22-bp DNA fragment (5′-GGAT[ATTTCCCGGGAAAT]{.ul}ATCC-3′) (3.6 mM in buffer that contains 10 mM Tris-HCl pH 8.0 and 250 mM NaCl) was heated to 95°C for 5 min before being left to cool at room temperature overnight to form a double stranded *NBS* DNA (final concentration: 1.8 mM). The 14-bp *NBS* site sequences are underlined.

### Protein crystallization, structure determination, and refinement {#sec4.4.8}

Crystallization screens were set up in sitting-drop vapor diffusion format in MRC2 96-well crystallization plates (Swissci) using either an OryxNano or an Oryx8 robot (Douglas Instruments) with drops comprised of 0.3 μL precipitant solution and 0.3 μL of protein-DNA complex, and incubated at 293 K. After optimization of initial hits, suitable crystals were cryoprotected with 20% (v/v) glycerol and mounted in Litholoops (Molecular Dimensions) before flash-cooling by plunging into liquid nitrogen. X-ray data were recorded on either beamline I04 or I03 at the Diamond Light Source (Oxfordshire, UK) using either a Pilatus 6M-F or an Eiger2 XE 16M hybrid photon counting detector (Dectris), respectively, with crystals maintained at 100 K by a Cryojet cryocooler (Oxford Instruments). Diffraction data were integrated and scaled using DIALS ([@bib71]) via the XIA2 expert system ([@bib70]) then merged using AIMLESS ([@bib15]). The Noc (DBD)-*NBS* dataset was further subjected to anisotropic correction using the STARANISO server as detailed below. Data collection statistics are summarized in [Table S4](#mmc1){ref-type="supplementary-material"}. The majority of the downstream analysis was performed through the CCP4i2 graphical user interface ([@bib49]).

### DNA-binding domain (DBD) ParB in complex with 20-bp *parS* {#sec4.4.9}

For crystallization, His-tagged DBD ParB (10 mg/mL) was mixed with a 20-bp *parS* site at a molar ratio of 1:1.2 (protein:DNA) in the elution buffer \[10 mM Tris-HCl pH 8.0, 250 mM NaCl\]. The DBD ParB-*parS* complex crystals grew in a solution containing 19% (w/v) PEG3350 and 49 mM lithium citrate.

The ParB (DBD)-*parS* complex crystallized in space group *C*2 with approximate cell parameters of *a* = 122.1, *b* = 40.7, *c* = 94.0 Å and β = 121.4° (Table S4). Analysis of the likely composition of the asymmetric unit (ASU) suggested that it would contain two copies of the ParB (DBD) bound to a single DNA duplex, giving an estimated solvent content of \~49%. A molecular replacement template covering the DBD was generated by manually editing the protein component of the structure of the Spo0J-*parS* complex from *Helicobacter pylori* ([@bib7]) (PDB accession code [4UMK](pdb:4UMK){#intref0155}; 42% identity over 75% of the sequence) and truncating all side-chains to Cβ atoms. For the DNA component, an ideal B-form DNA duplex was generated in COOT ([@bib14]) from the 20-bp palindromic sequence of *parS*. PHASER ([@bib39]) was used to place the DNA duplex, followed by two copies of the DBD template into the ASU. The placement of the DNA-binding domains with respect to the DNA duplex was analogous to that seen in the *Helicobacter* Spo0J-*parS* ([@bib7]), and an analysis of crystal contacts revealed that the DNA formed a pseudo-continuous filament spanning the crystal due to base-pair stacking between adjacent DNA fragments. After restrained refinement in REFMAC5 ([@bib44]) at 2.4 Å resolution, the protein component of the model was completely rebuilt using BUCCANEER ([@bib10]). The model was finalized after several iterations of manual editing in COOT and further refinement in REFMAC5 incorporating TLS restraints. The model statistics are reported in [Table S4](#mmc1){ref-type="supplementary-material"}.

### DNA-binding domain (DBD) Noc in complex with 22-bp *NBS* {#sec4.4.10}

Crystallization screens were set up in sitting-drop vapor diffusion format in MRC2 96-well crystallization plates with drops comprised of 0.3 μL precipitant solution and 0.3 μL of protein-DNA complex, and incubated at 293 K. Noc (DBD)-His~6~ (10 mg/mL) was mixed with a 22-bp *NBS* duplex at a molar ratio of 1:1.2 protein:DNA in buffer containing 10 mM Tris-HCl pH 8.0 and 250 mM NaCl. The Noc (DBD)-*NBS* crystals grew in a solution containing 20% (w/v) PEG 3350 and 200 mM di-potassium phosphate.

The Noc (DBD)-*NBS* complex crystallized in space group *C*2 with approximate cell parameters of *a* = 134.1, *b* = 60.6, *c* = 81.0 Å and β = 116.9°. The data were collected in two 360° sweeps separated by a χ offset of 20°. Data reduction in AIMLESS indicated that the diffraction was highly anisotropic, and thus before using the dataset, it was corrected using STARANISO with a local mean *I/σ(I)* threshold of 1.2, giving maximum and minimum anisotropic resolution cut-offs of 2.23 and 4.02 Å, respectively ([Table S4](#mmc1){ref-type="supplementary-material"}). Analysis of the likely composition of the asymmetric unit (ASU) suggested that it would contain two copies of the Noc (DBD) bound to a single DNA duplex, giving an estimated solvent content of \~69%. A molecular replacement template covering the DBD was generated from the ParB DBD structure above using SCULPTOR (41% identity overall) ([@bib5]). For the DNA component, an ideal B-form DNA duplex was generated from the 22-bp palindromic sequence of *NBS*. PHASER was used to place the DNA duplex, followed by two copies of the DBD template into the ASU. This generated a complex that was consistent with that of ParB (DBD)-*parS* determined above, again with the DNA forming a pseudo-continuous filament spanning the crystal due to base-pair stacking between adjacent DNA fragments. After restrained refinement in REFMAC5 at 2.23 Å resolution, the protein component of the model was completely rebuilt using BUCCANEER ([@bib10]). The model was finalized after several iterations of manual editing in COOT and further refinement in REFMAC5 incorporating TLS restraints. To avoid model bias resulting from the feature of REFMAC5 to approximate missing reflections within the spherical resolution cut-off to their calculated values, these filled-in reflections were removed prior to map inspection. Subsequently, the map connectivity was improved by applying a blurring factor of 60 Å^2^. The model statistics are reported in [Table S4](#mmc1){ref-type="supplementary-material"}.

### Identification of protein-DNA contacts and analysis of DNA shapes {#sec4.4.11}

Protein-DNA contacts were identified using the jsPISA webserver ([@bib28]). Superpositions of structures were performed using the *align/cealign* function in PyMOL. DNA shape parameters were determined from the structures using Curves+ ([@bib31]).

### Molecular dynamics simulations {#sec4.4.12}

We performed simulations of Noc (DBD)-*NBS* complex using its crystallographic structure as initial coordinates. Virginia Tech H++ web server ([@bib2]) was used for ensuring the correct protonated state of proteins at pH 7.0. Forcefields ff14SB ([@bib38]) and parmbsc1 ([@bib22]) were employed for describing protein and DNA, respectively. The system was solvated in a TIP3P octahedral periodic box ([@bib50]) with a 12 Å buffer and 100 mM of NaCl ions ([@bib58]). Minimization and equilibration were performed following a standard protocol ([@bib45]) at constant temperature (300 K) and pressure (1 atm). The structures were simulated for 200 ns with an integration time step of 2 fs. SHAKE method ([@bib55]) was used to constrain hydrogen bonds, alongside periodic boundary conditions and Particle-Mesh-Ewald algorithm ([@bib12]). These simulations were performed with CUDA implementation of AMBER 18's PMEMD module. After discarding the first 10 ns, trajectory was analyzed using cpptraj ([@bib54]) for describing the nature of protein:DNA interactions. Hydrogen bonds were determined using a distance cutoff of 3.5 Å between donor and acceptor atoms and an angle cutoff of 120°. Salt bridges were also established with a distance cutoff of 3.5 Å for a direct ion-pair contact between heavy atoms of charged groups and an increased cutoff of 6.0 Å for a solvent-separated ion-pair ([@bib8]).

### Measure protein-DNA binding affinity by bio-layer interferometry (BLI) {#sec4.4.13}

Bio-layer interferometry experiments were conducted using a BLItz system equipped with Dip-and-Read Streptavidin (SA) Biosensors (ForteBio). BLItz monitors wavelength shifts (response, unit: nm) resulting from changes in the optical thickness of the sensor surface during association or dissociation of the analyte over time to obtain kinetics data i.e., k~off~ and k~on~ of interactions. The streptavidin biosensor (ForteBio) was hydrated in a binding buffer \[100 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, and 0.005% Tween 20\] for at least 10 min before each experiment. Biotinylated dsDNA was immobilized onto the surface of the SA biosensor through a cycle of Baseline (30 s), Association (120 s), and Dissociation (120 s). Briefly, the tip of the biosensor was dipped into a low salt buffer for 30 s to establish the baseline, then to 1 μM biotinylated dsDNA for 120 s, and finally to a low salt binding buffer for 120 s to allow for dissociation. Biotinylated dsDNA harboring *parS*, *NBS*, or variant of such sites were prepared by annealing a 24-bp biotinylated oligo with its unmodified complementary strand in an annealing buffer \[1 mM Tris-HCl pH 8.0 and 5 mM NaCl\]. The oligos mixture was heated to 98°C for 2 min and allowed to cool down to room temperature overnight.

After immobilizing DNA on the sensor, we first screened for protein-DNA interactions using a high protein concentration (1000 nM dimer concentration) (282 unique protein-DNA pairs in total, triplicated screens). A protein-DNA pair was regarded as not interacting if no/very weak BLI response above background was observed at this concentration, hence K~D~ was not determined. For other protein-DNA pairs where we observed BLI responses at 1000 nM, experiments were extended to include a range of protein concentrations. The concentration used were typically 0, 31, 62, 125, 250, 500, and 1000 nM. For weaker protein-DNA pairs, higher concentrations such as 2000 and 4000 nM were also employed. At the end of each protein binding step, the sensor was transferred into a protein-free binding buffer to follow the dissociation kinetics for 120 s. The sensor could be recycled by dipping in a high-salt buffer \[100 mM Tris-HCl pH 7.4, 1000 mM NaCl, 1 mM EDTA, and 0.005% Tween 20\] for at least 1 min to remove bound proteins.

For every protein-DNA pair, we first measured the kinetics (i.e., response versus time) at 1000 nM in triplicate, using three independent protein aliquots. The kinetic profiles were deemed reproducible, with deviations less than 10%. Then, for [Figures 2](#fig2){ref-type="fig"}D and [3](#fig3){ref-type="fig"}C, we measured the kinetics once for each concentration (0, 31, 62, 125, 250, and 500 nM). Kinetics data were fitted locally, using an 1:1 binding model, for each protein concentration using BLItz Pro software (ForteBio) to determine k~off~, k~on~, and K~D~ (a ratio of k~off~/k~on~). The χ^2^ and R^2^ values were calculated, a local fitting was judged to be good if χ^2^ \< 3 and R^2^ \> 0.9. For a poor local fitting (i.e., χ^2^ \> 3 and R^2^ \< 0.9), typically because of a low BLI response at a low protein concentration, this datapoint was omitted from K~D~ calculation (BLI data analysis manual-ForteBio). Each calculated K~D~ at each concentration is considered as an independent determination of such value, hence we averaged to obtain mean K~D~ and standard deviation (SD) for each protein-DNA pair. For [Figure 3](#fig3){ref-type="fig"}A, we measured the kinetics in triplicate for every concentration in the range.

### Clustering of trajectory-scanning mutagenesis data {#sec4.4.14}

K~D~ of interactions between ParB (WT)/PtoN variants and each of the 16 DNA-binding sites were presented as a two-dimensional heatmap using the *heatmap* function in R. Euclidean distances were measured to obtain a distance matrix, and a complete agglomeration method, implemented within the *heatmap* function, was used for clustering.

### Chromatin immunoprecipitation with qPCR or deep sequencing {#sec4.4.15}

For *E. coli* ChIP-seq, cells harboring pUT18C-1xFLAG-ParB/Noc were grown in LB (25 mL) at 28°C to mid exponential phase (OD~600~ \~0.4) before 1 mM IPTG was added for 1-3 hours. The induction time (either 1, 2 or 3 hours) was chosen so that all ParB/Noc variants were produced to a similar level as judged by an α-FLAG western blot. Subsequently, formaldehyde is added to a final concentration of 1% to fix the cells.

Fixed cells were incubated at room temperature for 30 min, then quenched with 0.125 M glycine for 15 min at room temperature. Cells were washed three times with 1x PBS pH 7.4 and resuspended in 1 mL of buffer 1 \[20 mM K-HEPES pH 7.9, 50 mM KCl, 10% Glycerol, and Roche EDTA-free protease inhibitors\]. Subsequently, the cell suspension was sonicated on ice using a probe-type sonicator (8 cycles, 15 s on 15 s off, at setting 8) to shear the chromatin to below 1 kb, and the cell debris was cleared by centrifugation (20 min at 13,000 rpm at 4°C).

The supernatant was then transferred to a new 1.5 mL tube and the buffer conditions were adjusted to 10 mM Tris-HCl pH 8, 150 mM NaCl and 0.1% NP-40. Fifty microliters of the supernatant were transferred to a separate tube for control (the INPUT fraction) and stored at −20°C. In parallel, antibodies-coupled beads were washed off storage buffers before adding to the above supernatant. We employed α-FLAG antibodies coupled to agarose beads (Sigma Aldrich) for ChIP-seq of FLAG-ParB/Noc. Briefly, 100 μL of beads was washed off storage buffer by repeated centrifugation and resuspension in IPP150 buffer \[10 mM Tris-HCl pH 8, 150 mM NaCl and 0.1% NP-40\]. Beads were then introduced to the cleared supernatant and incubated with gentle shaking at 4°C overnight. In the next day, beads were then washed five times at 4°C for 2 min each with 1 mL of IPP150 buffer, then twice at 4°C for 2 min each in 1x TE buffer \[10 mM Tris-HCl pH 8 and 1 mM EDTA\]. Protein-DNA complexes were then eluted twice from the beads by incubating the beads first with 150 μL of the elution buffer \[50 mM Tris-HCl pH 8.0, 10 mM EDTA, and 1% SDS\] at 65°C for 15 min, then with 100 μL of 1x TE buffer + 1% SDS for another 15 min at 65°C. The supernatant (the ChIP fraction) was then separated from the beads and further incubated at 65°C overnight to completely reverse crosslink. The INPUT fraction was also de-crosslinked by incubation with 200 μL of 1x TE buffer + 1% SDS at 65°C overnight. DNA from the ChIP and INPUT fraction were then purified using the PCR purification kit (QIAGEN) according to the manufacturer's instruction, then eluted out in 50 μL of EB buffer (QIAGEN). The purified DNA was then used directly for qPCR or being constructed into library suitable for Illumina sequencing using the NEXT Ultra library preparation kit (NEB). ChIP libraries were sequenced on the Illumina HiSeq 2500 at the Tufts University Genomics facility. For the list of ChIP-seq datasets in this study, see [Table S5](#mmc1){ref-type="supplementary-material"}.

### Generation and analysis of ChIP-seq profiles {#sec4.4.16}

For analysis of ChIP-seq data, Hiseq 2500 Illumina short reads (50 bp) were mapped back to the *Escherichia coli* MG1655 reference genome using Bowtie1 ([@bib30]) and the following command: bowtie -m 1 -n 1--best--strata -p 4--chunkmbs 512 MG1655*-*bowtie--sam ^∗^.fastq \> output.sam

Subsequently, the sequencing coverage at each nucleotide position was computed using BEDTools ([@bib52]) using the following command: bedtools genomecov -d -ibam output.sorted.bam -g Ecoli_MG1655.fna \> coverage_output.txt

ChIP-seq profiles were plotted with the x axis representing genomic positions and the y axis is the number of reads per base pair per million mapped reads (RPBPM) using custom R scripts. To calculate the enrichment of reads at the *parS* or *NBS* site ([Figure S1](#mmc1){ref-type="supplementary-material"}B), we summed the RPBPM values for a 100-bp window surrounding the *parS* or *NBS* site.

### Bacterial one-hybrid assay coupled with deep sequencing (B1H-seq) {#sec4.4.17}

*Optimization of bacterial one-hybrid assays*. Bacterial one-hybrid (B1H) assays were performed as described previously ([@bib46]). Recipes for the minimal medium for B1H selection were described in detail previously ([@bib46]). Several parameters (promoter strength, spacers between the core −10 −35 promoter and the *NBS/parS* site, and IPTG concentration) were empirically optimized for experiments described in this work ([Figure S4](#mmc1){ref-type="supplementary-material"}). We found that induction of *ω-parB^∗^* from a weak *lacUV5mut* promoter, using 0.1 mM IPTG, minimizes toxicity to the cells. Also, a 19-bp spacer between the core −10 −35 promoter and the *parS/NBS* site is optimal for the induction of HIS3 URA3 but does not auto-induce these genes ([Figure S4](#mmc1){ref-type="supplementary-material"}). Therefore, we employed *pU3H3::19bp-parS* and *pU3H3::19bp-NBS* plasmids for all subsequent B1H selection.

*Construction of combinatorial plasmid libraries*. To construct combinatorial mutagenesis libraries where codons for Q173, K179, K184, and R201 were replaced with NNS (N = A/T/G/C, S = G/C), we employed round-the-horn PCR using oligos For_B\_NNS_HTH, Rev_B\_NNS_HTH, and pB1H2-P~*lacUV5mut*~*-Caulobacter* ParB (R104A + Q173K179K184R201) plasmid as template. Briefly, desalted oligos were reconstituted in 1x T4 ligase buffer, and 5′ phosphorylated using T4 PNK enzyme (NEB). Thirty 50μL PCR reactions were performed before DpnI was added and incubated overnight at 37°C to remove the methylated template. Next, PCR product (\~4.5 kb) was gel-purified and re-circularized overnight using T4 DNA ligase (NEB). The product was then ethanol precipitated to remove salts, and the DNA pellet was resuspended in 50 μL of water before being introduced into electrocompetent *E. coli* DH5α cells. Around 15 million carbenicillin-resistant *E. coli* colonies were collected, pooled together, and have their plasmid extracted (QIAGEN MiniPrep kit). The whole procedure was repeated two more times, and on different days, to obtain three independent combinatorial libraries. Libraries from \~15 million individual colonies ensure that at least 99% completeness is achieved ([@bib4]).

*Selection of ParB variants that bind to* NBS *or* parS. The selection strain TLE3001 (USO *rpoZ- hisB- pyrF-*) harboring either *pU3H3::19bp-NBS* or *pU3H3::19bp-parS* plasmid was made electrocompetent. Next, approximately 2 μg of the combinatorial plasmid library were electroporated into 100 μL of the selection strain. The procedure was repeated for four more times, and electroporated cells were recovered in 10 mL of LB for an hour at 37°C. Subsequently, cells were washed off rich LB medium and resuspended in 5ml of 1x M9 liquid. Cells were then plated out on ten 150 mm Petri plates containing M9-minus-histidine medium supplemented with 0.1 mM IPTG, 5 mM 3-AT (a competitive inhibitor of HIS3, to increase the stringency of the selection), and appropriate antibiotics. Plates were incubated at 37°C for 48 hours before cells were scrapped off the agar surface, pooled together, and had their plasmids extracted (QIAGEN Miniprep kit).

*Construction of deep sequencing libraries*. Illumina Truseq-compatible libraries were constructed from pre- and post-selection plasmid libraries via two rounds of PCR.

*PCR round 1*. Primer 4nns_R (10 μM): 2.5 μL

Mixture in equimolar amount of primers 4nns_offset_0\_F; 4nns_offset_1\_F; 4nns_offset_2\_F; 4nns_offset_3\_F; 4nns_offset_4\_F (10 μM): 2.5 μL. A mixture of forward primers were used to stagger reads across the amplicon to improve the distribution of base calls at each position during the initial rounds of Illumina sequencing.

dNTP (10mM): 1 μL

DMSO: 1.5 μL

Plasmid template (pre- or post-selection): 1 μL of 500 ng/μL

Phusion polymerase: 0.5 μL

5x HF buffer: 10 μL

Water: 31 μL

PCR program: 98°C for 30 s, (98°C for 10 s, 56°C for 20 s, 72°C for 10 s) x 20 cycles, 72°C for 5 min.

PCR products were gel-purified, quantified by Qubit hsDNA quantification kit (ThermoFisher), and used as template in the second PCR.

*PCR round 2*. NEBNext Index primer (NEB): 2.5 μL

NEBNext universal primer (NEB): 2.5 μL

dNTP (10mM): 1 μL

DMSO: 1.5 μL

Template: 5 μL of gel-purified DNA from PCR round 1

5x HF buffer: 10 μL

Phusion polymerase: 0.5 μL

Water: 27 μL

PCR program: 98°C for 30 s, (98°C for 10 s, 54°C for 20 s, 72°C for 10 s) x 12 cycles, 72°C for 5 min.

PCR products were gel-purified, quantified by Qubit hsDNA quantification kit (ThermoFisher), and were sequenced on the Illumina HiSeq 2500 (single-end, 150-bp read length, 15% spike-in phiX DNA) at the Tufts University Genomics facility. For the list of B1H-seq datasets in this study, see [Table S5](#mmc1){ref-type="supplementary-material"}.

### Analysis of data from deep mutational scanning experiments {#sec4.4.23}

*Processing deep sequencing reads*. We used fastx_trimmer script from the FASTX-Toolkit to remove nucleotides 0 to 20 and 114 to 150 from our reads using the following command: fastx_trimmer -f 20 -l 114 -Q33 -i TLE4_S4_R1_001.fastq -o TLE4_trimmed.fastq. Subsequently, we discarded sequence reads with an average Phred score \< 28, using the fastq_quality_filter script in the FASTX-Toolkit: fastq_quality_filter -v -Q33 -q 28 -p 100 -i TLE4_trimmed -o TLE4_trimmed_filtered.fastq. Reads were further filtered for the exact match to the following sequence:\[ATGC\]\[ATGC\]\[GC\]tctcacgtagcgaat\[ATGC\]\[ATGC\]\[GC\]atgcgtcttctt\[ATGC\]\[ATGC\]\[GC\]ttgccggacgaggtacagtcctatcttgtgagtggagagctgacagcg\[ATGC\]\[ATGC\]\[GC\]. Corresponding codons (bases 1-3, 19-21, 34-36, 85-87) for the four specificity residues were extracted from the above 87-bp nucleotide sequence, and subsequently translated to amino acid sequence, following the standard genetic code. Variants with stop codon (TAG) were removed and were not considered in subsequent steps. Because of a high reproducibility among replicates ([Figure S5](#mmc1){ref-type="supplementary-material"}C), we pooled reads from three replicates together ([Figure S5](#mmc1){ref-type="supplementary-material"}A). We counted the number of occurrences (counts) for each unique variant, and removed variants with less than 10 reads ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Greater than 94% of all 160,000 predicted variants were represented by at least 10 reads. The variant counts for pre-selection and post-selection (for *parS*- or *NBS*-binding) libraries were used in the following steps to estimate the fitness score of each variant.

*Calculation of fitness scores*. We calculated the fitness of each variant (ƒ~*parS*~ *and* ƒ~*NBS*~), in comparison to WT variants (RTAG or QKKR), as described previously ([@bib1]; [@bib67]).

ƒ~parS,\ raw~ = log~10~(N variant, *parS* post-selection library / N wt, *parS* post-selection library) - log~10~(N variant, pre-selection library / N wt, pre-selection library)

N variant, *parS* post-selection library = counts of each variant in the post-selection library for binding to *parS*.

N wt, *parS* post-selection library = counts of the WT (RTAG) in the post selection library for binding to *parS*.

N variant, pre-selection library = counts of each variant in the pre-selection (starting) library.

N wt, pre-selection library = counts of the WT (RTAG) in the pre-selection (starting) library.

ƒ~NBS,\ raw~ = log~10~(N variant, *NBS* post-selection library / N wt, *NBS* post-selection library) - log~10~(N variant, pre-selection library / N wt, pre-selection library)

N variant, *NBS* post-selection library = counts of each variant in the post-selection library for binding to *NBS*.

N wt, *NBS* post-selection library = counts of the WT (QKKR) in the post selection library for binding to *NBS*.

N variant, pre-selection library = counts of each variant in the pre-selection (starting) library.

N wt, pre-selection library = counts of the WT (QKKR) in the pre-selection (starting) library.

These raw fitness scores were further transformed so that *ƒ*~*parS*~ of the RTAG variant was 1 and that of QKKR variant was 0, and *ƒ*~*NBS*~ of the RTAG variant was 0 and that of QKKR variant was 1. The fitness scores for every variant were presented in the fitness scatterplot ([Figure 5](#fig5){ref-type="fig"}C). Dark green: strong *parS* binding, no *NBS* binding (fitness score: ƒ~*parS*~ ≥ 0.6, ƒ~*NBS*~ ≤ 0.2); light green: strong *parS* binding, weak-to-medium *NBS* binding (ƒ~*parS*~ ≥ 0.6, 0.2 ≤ ƒ~*NBS*~ ≤ 0.6); magenta: strong *NBS* binding, no *parS* binding (ƒ~*NBS*~ ≥ 0.6, ƒ~*parS*~ ≤ 0.2); pink: strong *NBS* binding, weak-to-medium *parS* binding (ƒ~*NBS*~ ≥ 0.6, 0.2 ≤ ƒ~*parS*~ ≤ 0.6); black: dual specificity i.e., bind strongly to both *parS* and *NBS* (ƒ~*NBS*~ ≥ 0.6 ƒ~*parS*~ ≥ 0.6). Frequency logos of each class of variants were constructed using WebLogo 3.0 ([@bib11])

*Reproducibility among replicates*. To check the reproducibility among replicates, we plotted log~10~(counts) of each variant in replicate 1 versus replicate 2 (and versus replicate 3). Only variants with more than four reads were included in such plot. We used R to calculate Pearson's correlation coefficients (*R*^*2*^) and to plot the linear best fit ([Figure S5](#mmc1){ref-type="supplementary-material"}C). We found that independent experiments were reproducible (*R*^*2*^ = 0.86-0.98) ([Figure S5](#mmc1){ref-type="supplementary-material"}C). Reads from three independent replicates were subsequently pooled together for the pre-selection, *parS* post-selection, and *NBS* post-selection experiments. Pooled reads were used to construct the scatterplot and frequency sequence logos ([Figure 5](#fig5){ref-type="fig"}C), and for the construction of the network graph ([Figure 6](#fig6){ref-type="fig"}B).

*Generation of force-directed networks graphs and analysis of shortest paths*. We constructed a force-directed graph that connects functional variants (nodes) together by lines (edges) if they are different by a single aa ([Figure 6](#fig6){ref-type="fig"}B). The node size is proportional to its connectivity (number of edges), and node colors represent different classes of functional variants ([Figure 6](#fig6){ref-type="fig"}B). Similarly, we also created a network graph in which edges represent variants that differ by a nt substitution, following a standard codon table ([Figure S7](#mmc1){ref-type="supplementary-material"}A). Force-directed graphs were generated using Gephi network visualization software. Node and edge files were prepared in R. The network layout was generated by running the ForceAtlas algorithm that was implemented in Gephi. Default parameters were used for the ForceAtlas algorithm, except that the repulsion and attraction strength were set to 200 and 10, respectively. The ForceAtlas algorithm arranged nodes in the two-dimensional space based on connectivity: nodes tend to repel each other but they are attracted to each other if these exists a connectivity (an edge). As the result of running the Force Atlas to completion, densely interconnected nodes are clustered together while less well-connected nodes are forced to different spatial locations. To analyze the properties of the network and the mutational paths that traverse the network, we employed the *igraph* package implemented in R. Our network did not include non-functional (gray) variants/nodes.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Information about statistical analysis and sample size for each experiment are detailed in the relevant [STAR Methods](#sec4){ref-type="sec"} sections.
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